Clinical Trial Update: A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)

View source ↗

Summary

A laboratory-based surveillance study investigating Candida bloodstream infections (Candidemia), sponsored by Merck Sharp & Dohme LLC, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia

Drugs mentioned

• MK-0991

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Candidemia | Status: COMPLETED